OpenNeedle Ask your own

Question explored with the scientific record

What are the side effects of long term Benadryl usage in women?

Sep 20, 2026 · 5 sources used · OpenNeedle synthesis
The retrieved studies do not directly answer the question about long-term Benadryl use in women, but they point to real risks that apply to anyone using it chronically.

The evidence here is thin for the specific question. The search found no long-term human studies on women taking diphenhydramine for months or years. What it did find are acute and animal studies that flag mechanisms of harm. One study in infant rats showed that diphenhydramine prolonged seizure duration during electroshock, a proconvulsant effect not seen with newer antihistamines [5]. Another study measured its anticholinergic strength: diphenhydramine has a pA2 value of 6.3, meaning it blocks acetylcholine receptors at the doses people take, which is the mechanism behind confusion, dry mouth, constipation, and urinary retention [4]. A single overdose case showed the drug concentrates heavily in reproductive tissues—73 µg/g in prostate tissue versus 4.9 µg/mL in blood—which raises a question about accumulation in women's reproductive organs that no study here answers [1].

The cognitive risk is real but the evidence is mixed. One study found diphenhydramine 50 mg caused a -1.36 point drop on a memory test, less than oxybutynin but still measurable [2]. Another study found no significant memory impairment from diphenhydramine at 25 or 50 mg, despite sedation [3]. The difference may be dose, duration, or individual susceptibility—the literature does not settle it.

The bottom line: chronic Benadryl use carries well-documented anticholinergic risks (dementia, constipation, falls) that the broader medical literature supports, but this specific search found no long-term safety data in women. The evidence that does exist comes from single-dose studies in mixed populations or animal models. A woman taking it nightly for sleep or allergies is taking a drug with known cognitive and anticholinergic harms, and the studies that would quantify her personal risk over years have not been run.

My call: the evidence is too thin to give a precise risk estimate for long-term use in women, but the mechanisms of harm are real and the drug should not be used chronically. Confidence: moderate.

Keep digging

Sources used 5

  1. Biodistribution of diphenhydramine in reproductive organs in an overdose case Human Cell (2016) Thin

    This study investigates the biodistribution of diphenhydramine and other motion sickness medications in the reproductive organs of a male overdose victim, revealing significantly higher concentrations in the prostate and testes compared to other tissues.

    DOI: 10.1007/s13577-016-0151-9
  2. Identification of Medications That Cause Cognitive Impairment in Older People: The Case of Oxybutynin Chloride Journal of the American Geriatrics Society (1998) Thin

    This study evaluates the cognitive effects of oxybutynin hydrochloride in older adults, demonstrating significant cognitive impairment compared to diphenhydramine and highlighting the need for monitoring cognitive performance in patients prescribed this medication.

    DOI: 10.1111/j.1532-5415.1998.tb01006.x
  3. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine Psychopharmacology (1998) Thin

    This study investigates the differential effects of scopolamine, lorazepam, and diphenhydramine on memory and event-related potentials (ERPs) in healthy participants, revealing that while both scopolamine and lorazepam impair memory, diphenhydramine does not, despite similar sed…

    DOI: 10.1007/s002130050482
  4. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models European Journal of Pharmacology (2005) Thin

    This study evaluates the comparative anticholinergic activities of 10 antihistamines using in vitro and in vivo models, revealing significant differences in their potencies and effectiveness.

    DOI: 10.1016/j.ejphar.2004.11.006
  5. Influences of Histamine H1 Receptor Antagonists on Maximal Electroshock Seizure in Infant Rats Biological and Pharmaceutical Bulletin (2007) Thin

    In infant rats, second-generation histamine H1 antagonists (epinastine and fexofenadine) showed no proconvulsant effects on maximal electroshock seizures, while several first-generation antagonists (diphenhydramine, chlorpheniramine, cyproheptadine, ketotifen) prolonged EEG and/…

    DOI: 10.1248/BPB.30.477

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question